Stenocoatsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2020-01-23
Share capital
5 000,00 PLN
Activity description

Stenocoat is a company that specializes in developing customized coatings for medical devices, including lubricious, drug-eluting, antibacterial, hydrophilic, and biocompatible coatings. They focus on urological devices such as catheters and stents, as well as cardiological stents, providing a complete R&D process from design to production and testing. Their services include adapting production lines for coating processes and conducting preclinical studies to evaluate functionality and safety.

Registered address
ul. Symboliczna 3/92, 01-252 Warszawa, Poland
Website
stenocoat.comWebsite active
Email
Email warning
Electronic delivery address
AE:PL-88853-29994-JWHDI-24

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 36.67kMedianUSD 38.31kAverageUSD 2.31m
Net profit
This companyUSD 2.29kMedianUSD -1.50kAverageUSD -84.98k
Operating costs
This companyUSD 34.04kMedianUSD 56.25kAverageUSD 2.29m
Assets
This companyUSD 8.98kMedianUSD 116.77kAverageUSD 2.72m

Bank accounts

Registered as a VAT taxpayer on 2020-02-04. Active

  • mBank
    14 1140 2004 0000 3002 7968 9135

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

Grant datePurposeGross amountGranting body
Feb 5, 2025
Aid for research and development projects: industrial research
$101,979Dyrektor Narodowego Centrum Badań i Rozwoju
Jun 22, 2020
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282Prezydent Miasta Stołecznego Warszawy

Tenders

No recorded participation in tenders.

Authorized Representatives

Kamil Michał Kopeć — President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Tomasz Adam Ciach (61)
50$675.3150%
Kamil Michał Kopeć (39)
50$675.3150%

Beneficial owners

PersonRights
Tomasz Adam Ciach (61)
Shareholder of a limited liability company, 2500.0 PLN
Kamil Michał Kopeć (39)
Shareholder of a limited liability company, 2500.0 PLN

Competitors

Selected automatically: mainly by similarity of the business description, plus comparable revenue, industry (PKD code) and location. Only companies with a complete profile (including a logo and financial data) are shown. The list is indicative.

NameRevenueWebsite
Medicofarma BiotechS.A.$314,882.33medicofarmabiotech.pl
Polskie Centrum Rozwoju Technologiisp. z o.o.$262,374.82pcrt.pl
Createcsp. z o.o.$250,174.08createc.com.pl
Countess Laboratoriessp. z o.o.$99,221.13countess.pl
Biostat Research And Developmentsp. z o.o.$50,225.77biostat.com.pl
Zawamedsp. z o.o.$43,909.06zawamed.pl
CadenasP.S.A.$31,138.51cadenas.tech
Nanostalsp. z o.o.$8,607.48nanostal.com
Oncotherics PolandS.A.$7,565.33oncotherics.com

Change history

DateEvent
2020-09-23Address change (Ul. Sienna 83/502, 00-815, Warszawa → Ul. Symboliczna 3/92, 01-252, Warszawa)
2020-01-23Entered in the register

FAQ

Last updated: 2026-07-18